Corticosteroids: rare risk of central serous chorioretinopathy with local as well as systemic administration

Central serous chorioretinopathy is a retinal disorder that has been linked to the systemic use of corticosteroids. Recently, it has also been reported after local administration of corticosteroids via inhaled and intranasal, epidural, intra-articular, topical dermal, and periocular routes.

Advice for healthcare professionals:

  • advise patients to report any blurred vision or other visual disturbances during corticosteroid treatment
  • consider referral to an ophthalmologist for evaluation of possible causes if a patient presents with vision problems
  • report suspected adverse reactions to us on a Yellow Card

Please see the MHRA Drug Safety Update website for more information.

Drug Safety Update volume 11 issue 1, August 2017: 2.